Tumor Immunology
Herausgeber: Browning, M. J.; Dalgleish, A. G.
Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
Tumor Immunology
Herausgeber: Browning, M. J.; Dalgleish, A. G.
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This 1996 volume reviewed advances in the field of human tumour immunology for an audience of clinicians and researchers.
Andere Kunden interessierten sich auch für
This 1996 volume reviewed advances in the field of human tumour immunology for an audience of clinicians and researchers.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 374
- Erscheinungstermin: 7. Januar 2015
- Englisch
- Abmessung: 235mm x 157mm x 27mm
- Gewicht: 759g
- ISBN-13: 9780521472371
- ISBN-10: 0521472377
- Artikelnr.: 22009099
- Verlag: Cambridge University Press
- Seitenzahl: 374
- Erscheinungstermin: 7. Januar 2015
- Englisch
- Abmessung: 235mm x 157mm x 27mm
- Gewicht: 759g
- ISBN-13: 9780521472371
- ISBN-10: 0521472377
- Artikelnr.: 22009099
Contributors; Series Editor's Preface; Abbreviations; 1. Introduction and
historical perspectives Michael Browning and A. G. Dalgleish; 2. The
immunosurveillance of cancer: specific and non-specific mechanisms Richard
G. Vile, Heung Chong and Sina Dorudi; 3. Antigen processing and
presentation Nicholas C. Testifo and Michael Wang; 4. The role of the MHC
class I in tumor immunity Michael Browning; 5. Human tumor antigens
recognized by Cytolytic T Lymphocytes Pierre G Coulie; 6. Peptide-specific
CTL directed against viral oncogene products Mariet C.W. Feltkamp, Cornelis
J. M. Melief and W. Martin Kast; 7. Cellular oncogenes for tumor immunity:
immunotherapy Hans J. Strauss and A. Maria Dahl; 8. Co-stimulatory
molecules and their role in tumour immunity A. G. Dalgleish; 9. The role of
cytokines in tumour rejection Guido Forni and Robin Foa; 10. Inhibition of
nonhemopoietic cancer cell growth by Interleukin-4 and related cytokines
Dave S. B. Hoon, Takashi Morisaki and Richard Essner; 11. Current concepts
concerning melanoma vaccines Donald L. Morton and Mepur H. Ravindranath;
12. Immune responses to mucins Rosalind A. Graham and Joyce
Taylor-Papadimitriou; 13. Heat shock protein-peptide complexes: pan-valent
vaccines against cancers and infectious diseases Ryuichiro Suto and Pramod
K. Srivastave; 14. The potential of gene transfer to alter the immune
response to tumors Bernard A. Fox and Gary J. Nabel; 15. Applications of
antibody gene technology Robert E. Hawkins and Kerry A. Chester; Index.
historical perspectives Michael Browning and A. G. Dalgleish; 2. The
immunosurveillance of cancer: specific and non-specific mechanisms Richard
G. Vile, Heung Chong and Sina Dorudi; 3. Antigen processing and
presentation Nicholas C. Testifo and Michael Wang; 4. The role of the MHC
class I in tumor immunity Michael Browning; 5. Human tumor antigens
recognized by Cytolytic T Lymphocytes Pierre G Coulie; 6. Peptide-specific
CTL directed against viral oncogene products Mariet C.W. Feltkamp, Cornelis
J. M. Melief and W. Martin Kast; 7. Cellular oncogenes for tumor immunity:
immunotherapy Hans J. Strauss and A. Maria Dahl; 8. Co-stimulatory
molecules and their role in tumour immunity A. G. Dalgleish; 9. The role of
cytokines in tumour rejection Guido Forni and Robin Foa; 10. Inhibition of
nonhemopoietic cancer cell growth by Interleukin-4 and related cytokines
Dave S. B. Hoon, Takashi Morisaki and Richard Essner; 11. Current concepts
concerning melanoma vaccines Donald L. Morton and Mepur H. Ravindranath;
12. Immune responses to mucins Rosalind A. Graham and Joyce
Taylor-Papadimitriou; 13. Heat shock protein-peptide complexes: pan-valent
vaccines against cancers and infectious diseases Ryuichiro Suto and Pramod
K. Srivastave; 14. The potential of gene transfer to alter the immune
response to tumors Bernard A. Fox and Gary J. Nabel; 15. Applications of
antibody gene technology Robert E. Hawkins and Kerry A. Chester; Index.
Contributors; Series Editor's Preface; Abbreviations; 1. Introduction and
historical perspectives Michael Browning and A. G. Dalgleish; 2. The
immunosurveillance of cancer: specific and non-specific mechanisms Richard
G. Vile, Heung Chong and Sina Dorudi; 3. Antigen processing and
presentation Nicholas C. Testifo and Michael Wang; 4. The role of the MHC
class I in tumor immunity Michael Browning; 5. Human tumor antigens
recognized by Cytolytic T Lymphocytes Pierre G Coulie; 6. Peptide-specific
CTL directed against viral oncogene products Mariet C.W. Feltkamp, Cornelis
J. M. Melief and W. Martin Kast; 7. Cellular oncogenes for tumor immunity:
immunotherapy Hans J. Strauss and A. Maria Dahl; 8. Co-stimulatory
molecules and their role in tumour immunity A. G. Dalgleish; 9. The role of
cytokines in tumour rejection Guido Forni and Robin Foa; 10. Inhibition of
nonhemopoietic cancer cell growth by Interleukin-4 and related cytokines
Dave S. B. Hoon, Takashi Morisaki and Richard Essner; 11. Current concepts
concerning melanoma vaccines Donald L. Morton and Mepur H. Ravindranath;
12. Immune responses to mucins Rosalind A. Graham and Joyce
Taylor-Papadimitriou; 13. Heat shock protein-peptide complexes: pan-valent
vaccines against cancers and infectious diseases Ryuichiro Suto and Pramod
K. Srivastave; 14. The potential of gene transfer to alter the immune
response to tumors Bernard A. Fox and Gary J. Nabel; 15. Applications of
antibody gene technology Robert E. Hawkins and Kerry A. Chester; Index.
historical perspectives Michael Browning and A. G. Dalgleish; 2. The
immunosurveillance of cancer: specific and non-specific mechanisms Richard
G. Vile, Heung Chong and Sina Dorudi; 3. Antigen processing and
presentation Nicholas C. Testifo and Michael Wang; 4. The role of the MHC
class I in tumor immunity Michael Browning; 5. Human tumor antigens
recognized by Cytolytic T Lymphocytes Pierre G Coulie; 6. Peptide-specific
CTL directed against viral oncogene products Mariet C.W. Feltkamp, Cornelis
J. M. Melief and W. Martin Kast; 7. Cellular oncogenes for tumor immunity:
immunotherapy Hans J. Strauss and A. Maria Dahl; 8. Co-stimulatory
molecules and their role in tumour immunity A. G. Dalgleish; 9. The role of
cytokines in tumour rejection Guido Forni and Robin Foa; 10. Inhibition of
nonhemopoietic cancer cell growth by Interleukin-4 and related cytokines
Dave S. B. Hoon, Takashi Morisaki and Richard Essner; 11. Current concepts
concerning melanoma vaccines Donald L. Morton and Mepur H. Ravindranath;
12. Immune responses to mucins Rosalind A. Graham and Joyce
Taylor-Papadimitriou; 13. Heat shock protein-peptide complexes: pan-valent
vaccines against cancers and infectious diseases Ryuichiro Suto and Pramod
K. Srivastave; 14. The potential of gene transfer to alter the immune
response to tumors Bernard A. Fox and Gary J. Nabel; 15. Applications of
antibody gene technology Robert E. Hawkins and Kerry A. Chester; Index.